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Introduction: Post-cardiac arrest patients are often exposed to 100% oxygen during cardiopulmonary resuscitation
and the early post-arrest period. It is unclear whether this contributes to development of pulmonary dysfunction or
other patient outcomes.
Methods: We performed a retrospective cohort study including post-arrest patients who survived and were
mechanically ventilated at least 24 hours after return of spontaneous circulation. Our primary exposure of interest was
inspired oxygen, which we operationalized by calculating the area under the curve of the fraction of inspired oxygen
(FiO2AUC) for each patient over 24 hours. We collected baseline demographic, cardiovascular, pulmonary and cardiac
arrest-specific covariates. Our main outcomes were change in the respiratory subscale of the Sequential Organ Failure
Assessment score (SOFA-R) and change in dynamic pulmonary compliance from baseline to 48 hours. Secondary
outcomes were survival to hospital discharge and Cerebral Performance Category at discharge.
Results: We included 170 patients. The first partial pressure of arterial oxygen (PaO2):FiO2 ratio was 241 ± 137, and
85% of patients had pulmonary failure and 55% had cardiovascular failure at presentation. Higher FiO2AUC was not
associated with change in SOFA-R score or dynamic pulmonary compliance from baseline to 48 hours. However,
higher FiO2AUC was associated with decreased survival to hospital discharge and worse neurological outcomes. This
was driven by a 50% decrease in survival in the highest quartile of FiO2AUC compared to other quartiles (odds ratio for
survival in the highest quartile compared to the lowest three quartiles 0.32 (95% confidence interval 0.13 to 0.79),
P = 0.003).
Conclusions: Higher exposure to inhaled oxygen in the first 24 hours after cardiac arrest was not associated with
deterioration in gas exchange or pulmonary compliance after cardiac arrest, but was associated with decreased survival
and worse neurological outcomes.Introduction
Over 500,000 Americans suffer a cardiac arrest (CA)
annually [1]. Among those with return of spontaneous
circulation (ROSC), 50 to 60% do not survive to hospital
discharge [2,3]. The post-arrest syndrome develops
commonly after CA, and is characterized by multiple organ* Correspondence: dezfulianc@upmc.edu
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injury and a systemic inflammatory response [4-6].
Pulmonary dysfunction and the acute respiratory distress
syndrome (ARDS) are components of this process.
Observational studies have associated higher arterial
oxygen concentration (hyperoxia) with worsened clin-
ical outcomes [7-10]. Authors of these studies have
hypothesized that this effect is mediated through
worsening of secondary brain injury by increased oxidative
stress and free radical formation, but other possible
explanations for this association have not been previouslyhis is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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ARDS through free-radical formation [11,12], and
although isolated respiratory failure is an uncommon
proximate cause of death after CA, lung dysfunction
is common and may worsen patient outcomes [13].
Preclinical data suggest that high concentrations of
oxygen cause pulmonary endothelial apoptotic cell death
and worsened lung injury [14-17]. However, there is an
important interaction between tidal volume (that is,
stretch-induced lung injury) and oxygen toxicity that may
explain this observation [18,19]. Indeed, early clinical
reports of pulmonary oxygen toxicity were conducted
when open-lung ventilation with high tidal volumes was
standard practice [20-22].
CA patients are often exposed to 100% oxygen during
cardiopulmonary resuscitation (CPR) and early after
ROSC [10]. Thus, this cohort is theoretically at risk for
oxygen-induced lung toxicity, which might help explain
the association between hyperoxia and patient outcomes.
Respiratory failure based on a higher sequential organ
failure assessment (SOFA) score has been associated
with increased mortality in two studies of CA outcomes
[23,24]. We analyzed data from a high-resolution CA
database to test the hypothesis that cumulative dose of
inhaled oxygen to which patients are exposed after CA
is associated with deterioration in lung function in the
first 48 h after ROSC. Second, we tested the association
between inhaled oxygen exposure and clinically relevant




We analyzed a prospective database of consecutive
in- and out-of-hospital CA patients cared for at UPMC
Presbyterian hospital by the Post-Cardiac Arrest Service
(PCAS). UPMC Presbyterian is a 798-bed tertiary care
center with approximately 54,000 emergency department
visits annually and 150 ICU beds. The PCAS treats over
350 survivors of CA annually and is part of local efforts to
regionalize and improve CA care. We have implemented
hospital-wide protocols to standardize and improve
post-CA care [25].
We included CA patients presenting between October
2008 (when electronic medical records were implemented
system-wide, permitting recording of vital signs and
ventilator data) and April 2010, who had a CA with
ROSC, survived and were mechanically ventilated for
a least 24 h. We included both in- and out-of-hospital CA
patients because 1) this reflects the true heterogeneity
encountered in clinical practice, 2) we hypothesized
that post-arrest organ dysfunction would be primarily
dependent on ischemia and reperfusion injury rather
than pathology present antecedent to the arrest, and3) we have previously demonstrated that the affect of
cardiopulmonary dysfunction on patient outcomes is
stable across arrest location [23]. We excluded patients if
the time of ROSC was unknown, if vital signs and
vasopressor requirements were not recorded within 6 h
of ROSC, or if arterial blood gas (ABG) or ventilator data
were not recorded within 4 h of ROSC (we have
previously reported that this is the timeframe during
which patients are most often exposed to high fraction of
inspired oxygen (FiO2) levels [10]). We further excluded
patients managed with extracorporeal membrane oxygen-
ation. The University of Pittsburgh Institutional Review
Board approved all aspects of this study with a waiver of
informed consent.
Primary exposure and covariates
Our primary exposure of interest was inhaled oxygen.
To quantify this exposure, we calculated the area under
the curve (AUC) of the FiO2 (FiO2AUC) for each patient
as follows. First, we recorded FiO2 values hourly for 24 h
after ROSC. Based on our local practice, we assumed all
patients were ventilated with an FiO2 of 1.0 during their
initial resuscitation until the first recorded value [10]. Next,
we summed these hourly values to derive the FiO2AUC.
This FiO2AUC could theoretically range from 5 (24 h on
room air at FiO2 = 0.21) to 24 (24 h on FiO2 = 1.0).
We abstracted demographic and basic clinical infor-
mation from our prospective CA registry, including
subject age, gender, location of arrest (out-of-hospital
versus in-hospital), initial arrest rhythm (ventricular
tachycardia or fibrillation (VT/VF) versus pulseless elec-
trical activity (PEA) or asystole) and use of hypothermia.
Additionally we abstracted each subject’s Pittsburgh CA
Category (PCAC). The PCAC is a clinical prediction tool
that stratifies post-arrest patients by their risk of subsequent
death or neurological deterioration based on clinical
characteristics during the first 6 h after ROSC [23]. This
tool divides patients into four categories that are strongly
predictive of survival and functional outcome.
We assessed baseline post-arrest pulmonary dysfunction
by recording each patient’s initial partial pressure of arterial
oxygen (PaO2):FiO2 (P:F) ratio and dynamic pulmonary
compliance, which we calculated as equal to tidal volume/
(peak inspiratory pressure minus positive end-expiratory
pressure (PEEP)). Additionally, we calculated the respira-
tory subscale of the SOFA scale (SOFA-R) [26]. To quantify
the degree of post-arrest cardiovascular dysfunction,
we calculated the baseline cardiovascular subscale of
the SOFA score (SOFA-CV), cumulative vasopressor
index (CVI), and shock index (mean arterial pressure/
heart rate). The SOFA score is a validated measure of
organ dysfunction commonly used in critical care research
[26]. The respiratory subscale assigns 0 to 4 points
based on the P:F ratio and requirement for mechanical
Elmer et al. Critical Care  (2015) 19:105 Page 3 of 9ventilation and the cardiovascular subscale assigns 0 to 4
points based on the presence of hypotension and
vasoactive medication requirement. The CVI is a method
of standardizing vasopressor dosing [26,27]. We calculated
the CVI from the highest vasopressor dose needed to
achieve a mean arterial pressure (MAP) >70 mmHg
within the first 6 h after ROSC.
Missing data
The baseline data necessary to calculate each patient’s
baseline SOFA score were unavailable in the first 6 h in
a small number of cases. In this situation, we used data
within 12 h of the time of interest. When PaO2 data
were unavailable even within 12 h of a given time point
(3.2% of cases), we calculated SOFA-R using peripheral
oxygen saturation (SpO2) which is recorded hourly based
on the following table, which we developed on the basis of a
previously validated SpO2:FiO2 estimation for P:F ratio [28].
Outcomes
The primary outcomes of interest were the change in
SOFA-R and dynamic pulmonary compliance over the
first 48 h after admission, and second, the changes in
SOFA-R and dynamic pulmonary compliance from 0
to 24 h and 0 to 72 h. As lung injury develops over
hours-to-days after the initial inflammatory or injurious
insult, we chose these time points to ensure we fully
captured the sequelae of the initial exposure [29].
Additional secondary outcomes of interest were 1)
survival to hospital discharge, and 2) neurological out-
comes, which we assessed by measuring the Pittsburgh
cerebral performance category (CPC) at hospital discharge.
Statistical analysis
We used Stata Version 13.1 (StataCorp, College Station,
TX, USA) for our analyses. We used linear regression to
test the association between baseline characteristics and
FiO2AUC. Next, we explored the association between
FiO2AUC and change in SOFA-R (using ordered logistic
regression) and change in dynamic pulmonary compliance
(using linear regression). Finally, we investigated the asso-
ciation between FiO2AUC and survival (using unadjusted
and multiple logistic regression) and neurological outcome
(using unadjusted and multiple ordered logistic regression).
In the adjusted models we included only variables
with unadjusted associations having outcomes with
P-values <0.2, to avoid over-fitting. We confirmed
the validity of the proportional odds assumption for
ordered logistic regression test procedures. As a post
hoc analysis, to determine whether baseline pulmonary
dysfunction or change in pulmonary dysfunction differed
between the in-hospital and out-of-hospital arrest popula-
tions, we stratified patients by arrest location and compared
their baseline SOFA-R, dynamic pulmonary complianceand the change in these values from baseline to 72 h
and 24 to 72 h using Fisher’s exact tests and t-tests
as appropriate.
To evaluate the possibility of a threshold effect for an
association between oxygen exposure and clinical outcomes,
we divided the population into quartiles based on FiO2AUC
and compared survival and neurological outcome between
these quartiles. Finally, to address the possibility of
confounding by indication (that is, severity of illness
may lead both to exposure to higher FiO2AUC and to
worse outcomes in the absence of causality), we performed
a propensity-adjusted analysis. We generated a saturated
propensity score incorporating all baseline covariates to
model the propensity for exposure to a higher quartile of
FiO2AUC given baseline clinical characteristics, and then
calculated the inverse probability of treatment weight
(IPTW) using the inverse of the propensity score and a
weight to reflect the sample size of each treatment group
[30,31]. After checking for and removing any extreme out-
lier IPTW values, we constructed adjusted models using
the IPTW to test for an independent association between
FiO2AUC quartile and change in SOFA-R and dynamic




Our initial registry query yielded 187 CA patients, of
whom 17 were transferred from outlying facilities late in
their post-arrest course and therefore excluded for
missing post-ROSC ABG, vital sign or ventilator data
based on our exclusion criteria, leaving 170 patients
for analysis. Mean age was 60 ± 6 years and 52%
were male (Table 1). The baseline PaO2:FiO2 ratio
was 241 ± 137, and quantified using SOFA subscales,
85% of patients had baseline pulmonary failure while 55%
had cardiovascular failure. Overall, pulmonary compliance
and SOFA-R scores improved daily, with a mean change
in SOFA-R of −0.7 ± 1.4 and a mean change in dynamic
pulmonary compliance of 3.8 ± 18.4 mL/cmH2O at 48 h
(Table 2). Neither baseline measure of pulmonary dys-
function nor change from baseline to 72 h or change from
24 to 72 h differed across arrest location (data not shown).
Patients with an initial arrest rhythm of VT/VF, lower
initial PaO2:FiO2 ratio, and more severe shock were
exposed to higher FiO2AUCs (Table 3).
Pulmonary dysfunction
In unadjusted analysis, FiO2AUC was not significantly
associated with increased SOFA-R from 0 to 48 h (Table 4).
No baseline predictors were associated with change in
dynamic pulmonary compliance from 0 to 48 h (data
not shown). In our adjusted model testing independent
predictors of change in SOFA-R from 0 to 48 h, FiO2
Table 1 Baseline population characteristics
Characteristic Overall Non-survivors Survivors
(n = 170) (n = 95) (n = 75)
Demographics
Age, years 60 ± 16 59 ± 17 63 ± 15
Male sex 89 (52%) 54 (61%) 35 (40%)
Arrest characteristics
Out-of-hospital arrest 96 (56%) 58 (61%) 38 (51%)
Initial rhythm VT/VF 64 (38%) 31 (33%) 33 (44%)
Therapeutic hypothermia used 113 (66%) 76 (80%) 37 (49%)
Pittsburgh cardiac
arrest category
1 28 (16%) 9 (9%) 19 (25%)
2 63 (37%) 26 (27%) 37 (49%)
3 32 (19%) 19 (20%) 13 (17%)
4 47 (28%) 41 (43%) 6 (8%)
Baseline physiologic and ventilator data
First PaO2:FiO2 ratio 241 ± 137 249 ± 129 231 ± 146
Dynamic compliance,
mL/cm H2O
29 ± 12 29 ± 12 28 ± 13
Initial SOFA-respiratory score
0 26 (15%) 13 (14%) 13 (17%)
1 33 (19%) 24 (25%) 9 (12%)
2 33 (19%) 17 (18%) 16 (21%)
3 46 (27%) 26 (27%) 20 (27%)
4 32 (19%) 15 (16%) 17 (23%)
Initial SOFA-cardiovascular score
0 76 (45%) 33 (35%) 43 (57%)
1 18 (11%) 8 (8%) 10 (13%)
2 10 (6%) 9 (9%) 1 (1%)
3 31 (18%) 22 (23%) 9 (12%)
4 25 (21%) 23 (24%) 12 (16%)
Cumulative vasopressor index 1.4 ± 1.9 1.7 ± 1.9 1.1 ± 1.9
Time to first FiO2 wean, h 6.3 ± 6.4 6.8 ± 6.9 5.8 ± 5.6
Number of FiO2 changes
in 24 h
2.5 ± 1.5 2.5 ± 1.6 2.6 ± 1.4
Data are presented as mean (standard deviation) or raw number with
corresponding percentage. VT/VF, ventricular tachycardia/fibrillation; PaO2,
partial pressure of arterial oxygen; FiO2, fraction of inspired oxygen; SOFA,
sequential organ failure assessment.




Change in SOFA-respiratory score
0 to 24 h −0.3 (1.5)
0 to 48 h −0.7 (1.4)
0 to 72 h −0.9 (1.5)
Change in lung compliance, ml/cmH2O
0 to 24 h 0.5 (13.9)
0 to 48 h 3.8 (18.4)







Survival to hospital discharge 75 (44%)
Data are presented as mean (standard deviation) or raw number with
corresponding percentage. SOFA, sequential organ failure assessment; CPC,
cerebral performance category.
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confidence interval (CI) 0.88, 1.04), P = 0.34).
Secondary outcomes
When we tested the association of FiO2AUC with
outcomes, we found that in both unadjusted and
adjusted analysis, higher FiO2AUC was associated with
significantly lower odds of survival (Table 5) and worse
CPC at hospital discharge (Additional file 1: Table S1and Additional file 2: Table S2). Although our model
did not violate the assumption of proportional odds,
stratifying patients by FiO2AUC quartile revealed that
this effect on mortality was driven by lower survival
among patients in the highest exposure quartile (OR
for survival in the highest quartile compared to the lowest
three quartiles 0.32 (95% CI 0.13 to 0.79), P = 0.003)
(Figure 1).
Propensity score-adjusted analysis
The above findings were replicated in our propensity
score-adjusted analysis, where only the highest quartile
of FiO2AUC exposure was associated with increased mor-
tality (P = 0.03). The change in SOFA-R and pulmonary
compliance from 0 to 48 h did not differ between this
quartile and the remaining three quartiles (P = 0.18 and
P = 0.39, respectively). Compared to the other quartiles,
the initial SOFA-R in this quartile was significantly higher
(median SOFA-R = 3 versus 1, 2 and 2 in quartiles 1 to 3,
respectively; P <0.001). A propensity-adjusted analysis
analyzing the affect of FiO2AUC on change in dynamic
pulmonary compliance was not possible (terms were not
uniquely estimable). In our propensity-adjusted analysis
for change in SOFA-R from 0 to 48 h, the highest quartile
of FiO2AUC was associated with improved SOFA-R com-
pared to the lowest quartile (OR 0.41, 95% CI (0.19-0.88),
P = 0.005) but there were no other significant differences
in outcome across quartiles.
Table 3 Unadjusted association between oxygen
exposure over the first 24 h after ROSC (FIO2AUC) and
baseline arrest and cardiopulmonary characteristics
Baseline predictor B coefficient (95% CI) P-value
Age −0.035 (−0.069 to −0.001) 0.04
Male sex 0.438 (−0.658 to 1.535) 0.43
Out-of-hospital arrest 0.304 (−0.802 to 1.410) 0.59
Arrest rhythm VT/VF 1.306 (0.191 to 2.421) 0.02
Received TH 0.355 (−0.806 to 1.516) 0.55
PCAC
1 Reference Reference
2 −0.246 (−1.823 to 1.332) 0.76
3 2.346 (0.548 to 4.143) 0.01
4 0.441 (−1.217 to 2.100) 0.60
First P:F ratio per 25 −0.262 (−0.354 to −0.170) <0.001
Initial pulmonary compliance 0.010 (−0.035 to 0.054) 0.67
Initial SOFA-respiratory score
0 Reference Reference
1 1.246 (−0.481 to 2.973) 0.16
2 1.703 (−0.024 to 3.430) 0.05
3 3.431 (1.815 to 5.047) <0.001
4 4.279 (2.540 to 6.018) <0.001
Initial SOFA-cardiovascular score
0 Reference Reference
1 −1.190 (−3.040 to 0.660) 0.21
2 0.145 (−2.230 to 2.519) 0.90
3 1.092 (−2.230 to 2.600) 0.15
4 1.245 (−0.197 to 2.686) 0.09
Initial cardiovascular index 0.346 (0.061 to 0.630) 0.02
Time to first FiO2 wean 0.012 (−0.074 to 0.099) 0.78
Number of FiO2 changes in 24 h −0.076 (−0.436 to 0.283) 0.68
VT/VF, ventricular tachycardia/ventricular fibrillation; TH, therapeutic
hypothermia; PCAC, Pittsburgh cardiac arrest category; P:F, ratio of partial
pressure of arterial oxygen (PaO2) to fraction of inspired oxygen (FiO2);
SOFA, sequential organ failure assessment.
Table 4 Unadjusted odds of change in the respiratory
subscale of the Sequential Organ Failure Assessment




FiO2 AUC 0.93 (0.86 to 1.02) 0.11
Age 1.00 (0.98 to 1.02) 0.86
Male sex 1.11 (0.62 to 2.00) 0.72
Out-of-hospital arrest 2.02 (1.11 to 3.67) 0.02
Arrest rhythm VT/VF 1.09 (0.78 to 2.00) 0.78
Received TH 2.74 (1.43 to 5.25) <0.01
PCAC
1 Reference Reference
2 2.24 (0.88 to 5.70) 0.09
3 0.87 (0.32 to 2.42) 0.80
4 2.58 (0.97 to 6.84) 0.06
Initial pulmonary compliance 0.98 (0.95 to 1.01) 0.24
Initial SOFA-cardiovascular score
0 Reference Reference
1 0.71 (0.27 to 1.85) 0.48
2 1.88 (0.50 to 7.04) 0.35
3 2.11 (0.93 to 4.77) 0.07
4 1.02 (0.47 to 2.24) 0.96
Initial CVI 1.04 (0.90 to 1.20) 0.62
Time to first FiO2 wean 0.99 (0.95 to 1.03) 0.67
Number of FiO2 changes in 24 h 0.82 (0.68 to 0.99) 0.04
*Odds ratios are presented per unit increase in respiratory subscale score.
FiO2, fraction of inspired oxygen; AUC, area under the curve; VT/VF, ventricular
tachycardia or ventricular fibrillation; TH, therapeutic hypothermia; PCAC,
Pittsburgh cardiac arrest category; SOFA, sequential organ failure assessment;
CVI, cumulative vasopressor index.
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We examined the association between inhaled oxygen
exposure and change in pulmonary function after
CA. Higher oxygen exposure in the initial 24 h was
strongly associated with the presence of baseline car-
diopulmonary dysfunction, but was not associated
with deterioration in pulmonary compliance or gas
exchange in the first 48 h after ROSC. In fact, in our
propensity-adjusted analysis, CA patients in the highest
quartile of oxygen exposure had improved lung function
compared to the lowest quartile of exposure. Despite
the absence of an association with change in lung
function, higher inhaled oxygen levels were independently
associated with decreased survival and worse neurologicaloutcomes. Taken together, these data suggest that
pulmonary oxygen toxicity is not a clinically important
mediator of the association between hyperoxia and patient
outcomes after CA.
A study of the Project IMPACT database found an
association between arterial hyperoxia and worsened
survival after CA [8]. The same authors reported
increasing odds of mortality in a linear fashion for
PaO2 values in excess of 100 mmHg, suggestive of
dose-dependent toxicity [9]. A significant limitation of this
work was the use of a single marker of hyperoxemia
(that is, first PaO2) without regard to underlying
physiologic dysfunction and without assessment of
subsequent time points. Furthermore, other large
database studies have failed to reproduce this finding
[32,33]. Unlike those prior, we have incorporated not
only physiologic measures of baseline lung diffusion
and cardiac function into our models, expanded our
analysis beyond the initial or highest level of oxygen-
ation, and controlled for the appropriate tendency of
Table 5 Unadjusted and adjusted associations between
predictors and odds of survival to hospital discharge
Baseline predictor Odds ratio (OR) P-value
Unadjusted OR (95% CI)
FiO2 AUC 0.90 (0.82 to 0.98) 0.02
Age 1.02 (1.00 to 1.04) 0.10
Male sex 0.66 (0.19 to 1.22) 0.19
Out-of-hospital arrest 0.66 (0.36 to 1.21) 0.18
Arrest rhythm VT/VF 1.62 (0.87 to 3.03) 0.13
Received TH 0.24 (0.13 to 0.48) <0.001
PCAC
1 Reference Reference
2 0.67 (0.26 to 1.72) 0.41
3 0.32 (0.11 to 0.94) 0.04
4 0.07 (0.02 to 0.22) <0.001
First P:F ratio 1.00 (1.00 to 1.00) 0.38
Initial pulmonary compliance 0.99 (0.97 to 1.02) 0.68
Initial SOFA-respiratory score 0.23
0 Reference Reference
1 0.38 (0.13 to 1.11) 0.08
2 0.94 (0.34 to 2.63) 0.91
3 0.77 (0.29 to 2.02) 0.59
4 1.13 (0.40 to 3.19) 0.81
Initial SOFA-cardiovascular score <0.01
0 Reference Reference
1 0.95 (0.34 to 2.70) 0.94
2 0.09 (0.01 to 0.71) 0.02
3 0.31 (0.13 to 0.77) 0.01
4 0.40 (0.17 to 0.92) 0.03
Initial CVI 0.82 (0.69 to 0.98) 0.03
Time to first vent wean 1.04 (1.00 to 1.10) 0.08
Number of vent weans in 24 h 0.79 (0.64 to 0.98) 0.03
Adjusted OR (95% CI)
FiO2 AUC 0.86 (0.76 to 0.97) 0.02
Age 1.01 (0.98 to 1.04) 0.38
Male sex 0.52 (0.23 to 1.18) 0.12
Out-of-hospital arrest 1.48 (0.52 to 4.23) 0.46
Arrest rhythm VT/VF 1.53 (0.62 to 3.77) 0.35
Received TH 0.19 (0.07 to 0.58) <0.01
PCAC
1 Reference Reference
2 1.25 (0.33 to 4.79) 0.74
3 0.91 (0.24 to 3.51) 0.89
4 0.13 (0.03 to 0.58) <0.01
Initial SOFA-cardiovascular score
0 Reference Reference
Table 5 Unadjusted and adjusted associations between
predictors and odds of survival to hospital discharge
(Continued)
1 0.62 (0.14 to 2.69) 0.52
2 0.05 (0.00 to 0.71) 0.03
3 0.23 (0.04 to 1.31) 0.10
4 0.12 (0.01 to 1.73) 0.12
Initial CVI 1.29 (0.73 to 2.26) 0.38
Time to first vent wean 0.78 (0.95 to 1.10) 0.13
Number of vent weans in 24 h 1.03 (0.58 to 1.07) 0.49
FiO2, fraction of inspired oxygen; AU, area under the curve; VT/VF, ventricular
tachycardia or ventricular fibrillation; TH, therapeutic hypothermia; PCAC,
Pittsburgh cardiac arrest category; P:F, partial pressure of arterial oxygen to
fraction of inspired oxygen; SOFA, sequential organ failure assessment; CVI,
cumulative vasopressor index.
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cardiopulmonary dysfunction.
Our study also differs from previous work in that it
examines both surrogate endpoints of pulmonary dys-
function as well as clinically meaningful endpoints. Our
results reflect that oxygen exposure was increased in those
with the worst early cardiopulmonary dysfunction, which
one would expect if oxygen were being titrated based on
the clinical assessment of the patient. There was no
association between the time to first FiO2 wean or
the total number of adjustments made in 24 h, suggesting
that higher FiO2AUC is not a surrogate marker for less
attentive care. The correlation between oxygen exposure
and SOFA-R, which is based on the PaO2:FiO2 ratio, is
consistent with the appropriate dosing of patients
with reduced oxygen diffusive capacity with higher inspired
oxygen. The loss of association when comparing early
oxygen exposure to subsequent changes in measures
of pulmonary dysfunction (SOFA-R or compliance) is
contradictory to the notion that early oxygen toxicity
results in subsequent lung injury.
Importantly, despite observing no association between
oxygen exposure and pulmonary dysfunction, we observed
significantly worse survival in the quartile of CA patients
with the highest oxygen exposure (25% versus 50%,
P = 0.003), which remained significant in adjusted
analysis and in our propensity-adjusted analysis. This
may be explained by the fact that this quartile had
the highest baseline SOFA-R scores and may have
been sicker than the other quartiles. However, this
excess mortality is also consistent with the findings
from the Project IMPACT database, although we did
not observe a linear dose-response curve as they did.
Rather, we observed what appears to be a threshold effect
where toxicity accrued only after FiO2 exceeded an average
of 0.75 over 24 h. If oxidative stress after CA worsens
outcomes [34-36] then it is likely that neuronal injury,
rather than pulmonary toxicity, drives this effect. Indeed,
Figure 1 Cerebral performance category stratified by quartile of fraction of inspired oxygen area under the curve (FiO2AUC).
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[37], though pulmonary dysfunction may play a role,
particularly after in-hospital CA [24]. We hypothesize
that the threshold for toxicity we observed occurs at
the level of exposure at which oxidative stress exceeds
antioxidant reserves. Thus, it may be most desirable
to decrease FiO2 in patients receiving the highest
oxygen exposure. Though this would seem intuitive, a
recent report revealed that as many as 18% of hyperoxic
patients receiving FiO2 >0.80 have neither their FiO2 nor
their PEEP weaned [38].
There are limitations to our study, which are common
to retrospective observational studies. Because patients
in our study were not randomized, we cannot determine
causality. A significant concern in this type of observational
study is confounding by indication, whereby sicker patients
may also be at higher risk of oxygen exposure, whether
appropriate or inappropriate, due to their severity of illness.
Propensity-adjusted analysis may partially control for this
phenomenon, and our propensity-adjusted analysis for
survival replicated our findings. Moreover, in the same
propensity-adjusted analysis, those patients in the highest
quartile of oxygen exposure had improved lung function
over 24 h compared to those in the lowest quartile of
exposure, further strengthening our assertion that
pulmonary oxygen toxicity is not a clinically relevant
phenomenon in this patient population. We believe a
randomized study would be difficult to perform ethically
with the present concerns over hyperoxia after CA, so
well-adjusted observational studies are the highest level of
evidence possible. Furthermore, our outcome measures
(change in SOFA-R and dynamic pulmonary compliance)
do not fully represent change in lung dysfunction orthe potential for pulmonary oxygen toxicity. There
are no compelling data to suggest whether compli-
ance or oxygenation is a better measure of lung dys-
function. As P:F ratio is commonly used in studies of
acute lung injury, and previous animal studies have
used pulmonary dynamic compliance as a measure of
lung function [39,40], we chose to measure both.
However, it is important to note that P:F ratio can
vary across FiO2 irrespective of changes in pulmonary
function [41], and post-arrest patients often have
significant changes made in FiO2 in the first 24 h
after ROSC [10]. We believe that we chose the two
best measures of lung dysfunction that can be obtained in
an observational clinical study, but they are nevertheless
imperfect.
Since our work was retrospective, we did not perform
a power calculation a priori, and unfortunately post hoc
power calculations have little statistical meaning or
utility [42], but our main findings may have resulted
from a type II error. Additionally, the observational
nature of our study means that our blood gases were
not all collected at standardized times and so we
were forced to estimate PaO2:FiO2 ratios and SOFA-R
scores using either closely timed blood gases or pulse
oximetry data. Further, by limiting our analysis to CA
patients who survived and were ventilated ≥24 h, we
excluded both the sickest and the healthiest post-arrest
patients. Patients who are extubated within 24 h after a
CA generally have very good outcomes while withdrawal
of care within 24 h is generally due to extremely grim
prognosis. By excluding these patients, our analysis may
exaggerate the magnitude of the association between
oxygen exposure and mortality.
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Our findings suggest that high levels of inhaled oxygen
are not associated with deterioration in gas exchange or
pulmonary compliance after cardiac arrest. However,
oxygen exposure was associated with decreased survival
to discharge and worse neurological outcomes. Taken
together, it does not appear that pulmonary oxygen
toxicity mediates the association between hyperoxia and
poor outcomes after cardiac arrest.
Key messages
 Post-arrest patients are often exposed to 100%
oxygen during cardiopulmonary resuscitation and the
post-arrest period, raising concern for the potential
for pulmonary oxygen toxicity.
 This study suggests that higher oxygen exposure is
not associated with subsequent pulmonary
dysfunction after cardiac arrest.
 At extreme levels, high oxygen exposure was
associated with decreased survival to discharge,
probably related to worsened neurological injury.
 We suggest avoiding prolonged exposure to a
FiO2 > 0.75 in the early post-arrest period unless
necessary to prevent hypoxia.
Additional files
Additional file 1: Table S1. Unadjusted associations between
exposures and discharge cerebral performance category. Abbreviations:
FiO2 – Fraction of inspired oxygen; AUC – Area under the curve;
VT/VF – Ventricular tachycardia or ventricular fibrillation; TH – Therapeutic
hypothermia; PCAC – Pittsburgh Cardiac Arrest Category; P:F – Partial
pressure of arterial oxygen to fraction of inspired oxygen; SOFA – Sequential
Organ Failure Assessment; CVI – Cumulative vasopressor index;
OR – Odds ratio.
Additional file 2: Table S2. Adjusted associations between exposures
and discharge cerebral performance category. Abbreviations:
FiO2 – Fraction of inspired oxygen; AUC – Area under the curve;
VT/VF – Ventricular tachycardia or ventricular fibrillation; TH – Therapeutic
hypothermia; PCAC – Pittsburgh Cardiac Arrest Category; SOFA –
Sequential Organ Failure Assessment; CVI – Cumulative vasopressor index;
OR – Odds ratio.
Abbreviations
ARDS: acute respiratory distress syndrome; AUC: area under the curve;
CA: cardiac arrest; CPC: Pittsburgh cerebral performance category;
CPR: cardiopulmonary resuscitation; CVI: cardiovascular index; FiO2: fraction
of inspired oxygen; FiO2AUC: area under the curve of the fraction of inspired
oxygen for each patient over 24 h; IPTW: inverse probability of treatment
weight; MAP: mean arterial pressure; PaO2: partial pressure of arterial oxygen;
PCAC: Pittsburgh cardiac arrest category; PCAS: Pittsburgh post-cardiac arrest
service; PEA: pulseless electrical activity; PEEP: positive end-expiratory
pressure; ROSC: return of spontaneous circulation; SOFA: sequential organ
failure assessment score; SOFA-CV: cardiovascular subscale of the sequential
organ failure assessment score; SOFA-R: respiratory subscale of the sequential
organ failure assessment score; VT/VF: ventricular tachycardia or fibrillation.
Competing interests
The authors declare that they have no competing interests.Authors’ contributions
JE assisted with data acquisition, statistical analysis, and data interpretation,
and drafted the manuscript. BW, SM, RP, NV and JB participated in the
design of the study, substantially contributed to data acquisition and
provided critical revisions to the manuscript. BR performed portions of the
statistical analysis and assisted with data interpretation. AAD and CWC
substantially contributed to analysis and interpretation of the data, and
provided critical revisions to the manuscript. CD conceived of the study,
substantially contributed to analysis and interpretation of the data, and
provided critical revisions to the manuscript. All authors read and approved
the manuscript in its final version and agree to be accountable for all
aspects of the work including its accuracy and integrity.
Authors’ information
Appendix: The Pittsburgh Post-Cardiac Arrest Service investigators: Clifton W.
Callaway, Cameron Dezfulian, Ankur A. Doshi, Jonathan Elmer, Francis X.
Guyette, and Jon C. Rittenberger.
Acknowledgements
Dr Dezfulian’s research time is supported by the NHLBI K08NS069817.
Dr Elmer’s research time is supported by the NHLBI 5K12HL109068.
Dr Rosario’s time is supported by the NIH CTSA program grant UL1TR000005.
Author details
1Safar Center for Resuscitation Research, University of Pittsburgh School of
Medicine, 100 Hill Building, 3434 Fifth Avenue, Pittsburgh, PA 15260, USA.
2Department of Critical Care Medicine, University of Pittsburgh School of
Medicine, Pittsburgh, USA. 3Department of Emergency Medicine, University
of Pittsburgh School of Medicine, Pittsburgh, USA. 4Department of
Anesthesiology, New York University Langone Medical Center, Pittsburgh,
USA. 5Department of Internal Medicine, University of Pittsburgh Medical
Center Mercy Hospital, Pittsburgh, USA. 6Department of Epidemiology,
Graduate School of Public Health, University of Pittsburgh, Pittsburgh, USA.
7Vascular Medicine Institute, University of Pittsburgh School of Medicine,
Pittsburgh, USA.
Received: 6 October 2014 Accepted: 19 February 2015
References
1. Roger VL, Go AS, Lloyd-Jones DM, Benjamin EJ, Berry JD, Borden WB, et al.
Heart disease and stroke statistics–2012 update: a report from the American Heart
Association. Circulation. 2012;125(1):e2–220. doi:10.1161/CIR.0b013e31823ac046.
2. Peberdy MA, Kaye W, Ornato JP, Larkin GL, Nadkarni V, Mancini ME, et al.
Cardiopulmonary resuscitation of adults in the hospital: a report of 14720
cardiac arrests from the National Registry of Cardiopulmonary Resuscitation.
Resuscitation. 2003;58(3):297–308.
3. Stiell IG, Wells GA, Field B, Spaite DW, Nesbitt LP, De Maio VJ, et al.
Advanced cardiac life support in out-of-hospital cardiac arrest. N Engl J
Med. 2004;351(7):647–56. doi:10.1056/NEJMoa040325.
4. Negovsky VA. The second step in resuscitation–the treatment of the
‘post-resuscitation disease’. Resuscitation. 1972;1(1):1–7.
5. Neumar RW, Nolan JP, Adrie C, Aibiki M, Berg RA, Bottiger BW, et al.
Post-cardiac arrest syndrome: epidemiology, pathophysiology, treatment,
and prognostication. A consensus statement from the International Liaison
Committee on Resuscitation (American Heart Association, Australian and
New Zealand Council on Resuscitation, European Resuscitation Council,
Heart and Stroke Foundation of Canada, InterAmerican Heart Foundation,
Resuscitation Council of Asia, and the Resuscitation Council of Southern
Africa); the American Heart Association Emergency Cardiovascular Care
Committee; the Council on Cardiovascular Surgery and Anesthesia; the
Council on Cardiopulmonary, Perioperative, and Critical Care; the Council
on Clinical Cardiology; and the Stroke Council. Circulation.
2008;118(23):2452–83. doi:10.1161/CIRCULATIONAHA.108.190652.
6. Negovsky VA. Postresuscitation disease. Crit Care Med. 1988;16(10):942–6.
7. Ferguson LP, Durward A, Tibby SM. Relationship between arterial partial
oxygen pressure after resuscitation from cardiac arrest and mortality in
children. Circulation. 2012;126(3):335–42. doi:10.1161/
CIRCULATIONAHA.111.085100.
8. Kilgannon JH, Jones AE, Shapiro NI, Angelos MG, Milcarek B, Hunter K, et al.
Association between arterial hyperoxia following resuscitation from
Elmer et al. Critical Care  (2015) 19:105 Page 9 of 9cardiac arrest and in-hospital mortality. JAMA. 2010;303(21):2165–71.
doi:10.1001/jama.2010.707.
9. Kilgannon JH, Jones AE, Parrillo JE, Dellinger RP, Milcarek B, Hunter K, et al.
Relationship between supranormal oxygen tension and outcome after
resuscitation from cardiac arrest. Circulation. 2011;123(23):2717–22.
doi:10.1161/CIRCULATIONAHA.110.001016.
10. Elmer J, Scutella M, Pullalarevu R, Wang B, Vaghasia N, Trzeciak S, et al. The
association between hyperoxia and patient outcomes after cardiac arrest:
analysis of a high-resolution database. Intensive Care Med. 2015;41(1):49–57.
doi:10.1007/s00134-014-3555-6.
11. Pagano A, Barazzone-Argiroffo C. Alveolar cell death in hyperoxia-induced
lung injury. Ann NY Acad Sci. 2003;1010:405–16.
12. Bhandari V. Molecular mechanisms of hyperoxia-induced acute lung injury.
Front Biosci. 2008;13:6653–61.
13. Peberdy MA, Callaway CW, Neumar RW, Geocadin RG, Zimmerman JL,
Donnino M, et al. Part 9: post-cardiac arrest care: 2010 American Heart Asso-
ciation Guidelines for Cardiopulmonary Resuscitation and Emergency Car-
diovascular Care. Circulation. 2010;122(18 Suppl 3):S768–86. doi:10.1161/
CIRCULATIONAHA.110.971002.
14. Matute-Bello G, Frevert CW, Martin TR. Animal models of acute lung injury.
Am J Physiol Lung Cell Mol Physiol. 2008;295(3):L379–99. doi:10.1152/
ajplung.00010.2008.
15. Altemeier WA, Sinclair SE. Hyperoxia in the intensive care unit: why more is
not always better. Curr Opin Crit Care. 2007;13(1):73–8. doi:10.1097/
MCC.0b013e32801162cb.
16. De Paepe ME, Mao Q, Chao Y, Powell JL, Rubin LP, Sharma S.
Hyperoxia-induced apoptosis and Fas/FasL expression in lung
epithelial cells. Am J Physiol Lung Cell Mol Physiol. 2005;289(4):L647–59.
doi:10.1152/ajplung.00445.2004.
17. He CH, Waxman AB, Lee CG, Link H, Rabach ME, Ma B, et al. Bcl-2-related
protein A1 is an endogenous and cytokine-stimulated mediator of
cytoprotection in hyperoxic acute lung injury. J Clin Invest.
2005;115(4):1039–48. doi:10.1172/JCI23004.
18. Sinclair SE, Altemeier WA, Matute-Bello G, Chi EY. Augmented lung injury
due to interaction between hyperoxia and mechanical ventilation. Crit Care
Med. 2004;32(12):2496–501.
19. Liu YY, Liao SK, Huang CC, Tsai YH, Quinn DA, Li LF. Role for nuclear
factor-kappaB in augmented lung injury because of interaction between
hyperoxia and high stretch ventilation. Transl Res. 2009;154(5):228–40.
doi:10.1016/j.trsl.2009.06.006.
20. Barber RE, Hamilton WK. Oxygen toxicity in man. N Engl J Med. 1970;283
(27):1478–84. doi:10.1056/NEJM197012312832702.
21. Kapanci Y, Tosco R, Eggermann J, Gould VE. Oxygen pneumonitis in man.,
Light- and electron-microscopic morphometric studies. Chest.
1972;62(2):162–9.
22. Nash G, Blennerhassett J, Pontoppidan H. Pulmonary lesions associated with
oxygen therapy and artificial ventilation. Laval Med. 1968;39(1):59–64.
23. Rittenberger JC, Tisherman SA, Holm MB, Guyette FX, Callaway CW. An
early, novel illness severity score to predict outcome after cardiac arrest.
Resuscitation. 2011;82(11):1399–404. doi:10.1016/j.resuscitation.2011.06.024.
24. Roberts BW, Kilgannon JH, Chansky ME, Mittal N, Wooden J, Parrillo JE, et al.
Multiple organ dysfunction after return of spontaneous circulation in
postcardiac arrest syndrome. Crit Care Med. 2013;41(6):1492–501.
doi:10.1097/CCM.0b013e31828a39e9.
25. Rittenberger JC, Guyette FX, Tisherman SA, DeVita MA, Alvarez RJ, Callaway
CW. Outcomes of a hospital-wide plan to improve care of comatose survivors
of cardiac arrest. Resuscitation. 2008;79(2):198–204. doi:10.1016/j.
resuscitation.2008.08.014.
26. Vincent JL, Moreno R, Takala J, Willatts S, De Mendonca A, Bruining H, et al.
The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ
dysfunction/failure. On behalf of the Working Group on Sepsis-Related
Problems of the European Society of Intensive Care Medicine. Intensive Care
Med. 1996;22(7):707–10.
27. Trzeciak S, McCoy JV, Phillip Dellinger R, Arnold RC, Rizzuto M, Abate NL,
et al. Early increases in microcirculatory perfusion during protocol-directed
resuscitation are associated with reduced multi-organ failure at 24 h in
patients with sepsis. Intensive Care Med. 2008;34(12):2210–7. doi:10.1007/
s00134-008-1193-6.
28. Pandharipande PP, Shintani AK, Hagerman HE, St Jacques PJ, Rice TW,
Sanders NW, et al. Derivation and validation of Spo2/Fio2 ratio to impute
for Pao2/Fio2 ratio in the respiratory component of the Sequential OrganFailure Assessment score. Crit Care Med. 2009;37(4):1317–21. doi:0.1097/
CCM.0b013e31819cefa9.
29. Johnson ER, Matthay MA. Acute lung injury: epidemiology, pathogenesis,
and treatment. J Aerosol Med Pulm Drug Deliv. 2010;23(4):243–52.
doi:10.1089/jamp.2009.0775.
30. Harder VS, Stuart EA, Anthony JC. Propensity score techniques and the
assessment of measured covariate balance to test causal associations in
psychological research. Psychol Methods. 2010;15(3):234–49. doi:10.1037/
a0019623.
31. Robins JM, Hernan MA, Brumback B. Marginal structural models and causal
inference in epidemiology. Epidemiology. 2000;11(5):550–60.
32. Ihle JF, Bernard S, Bailey MJ, Pilcher DV, Smith K, Scheinkestel CD. Hyperoxia
in the intensive care unit and outcome after out-of-hospital ventricular fibrillation
cardiac arrest. Crit Care Resusc. 2013;15(3):186–90.
33. Bellomo R, Bailey M, Eastwood GM, Nichol A, Pilcher D, Hart GK, et al.
Arterial hyperoxia and in-hospital mortality after resuscitation from cardiac
arrest. Crit Care. 2011;15(2):R90. doi:10.1186/cc10090.
34. Dohi K, Miyamoto K, Fukuda K, Nakamura S, Hayashi M, Ohtaki H, et al.
Status of systemic oxidative stress during therapeutic hypothermia in
patients with post-cardiac arrest syndrome. Oxidative Med Cell Longev.
2013;2013:562429. doi:10.1155/2013/562429.
35. Liu Y, Rosenthal RE, Haywood Y, Miljkovic-Lolic M, Vanderhoek JY, Fiskum G.
Normoxic ventilation after cardiac arrest reduces oxidation of brain lipids
and improves neurological outcome. Stroke. 1998;29(8):1679–86.
36. Vereczki V, Martin E, Rosenthal RE, Hof PR, Hoffman GE, Fiskum G. Normoxic
resuscitation after cardiac arrest protects against hippocampal oxidative
stress, metabolic dysfunction, and neuronal death. J Cereb Blood Flow
Metab. 2006;26(6):821–35. doi:10.1038/sj.jcbfm.9600234.
37. Laver S, Farrow C, Turner D, Nolan J. Mode of death after admission to an
intensive care unit following cardiac arrest. Intensive Care Med.
2004;30(11):2126–8. doi:10.1007/s00134-004-2425-z.
38. de Graaff AE, Dongelmans DA, Binnekade JM, de Jonge E. Clinicians’ response
to hyperoxia in ventilated patients in a Dutch ICU depends on the level of
FiO2. Intensive Care Med. 2011;37(1):46–51. doi:10.1007/s00134-010-2025-z.
39. Clark WT, Jones BR, Clark J. Dynamic pulmonary compliance as a
measurement of lung function in dogs. Vet Rec. 1977;101(25):497–9.
40. Martin TR, Gerard NP, Galli SJ, Drazen JM. Pulmonary responses to
bronchoconstrictor agonists in the mouse. J Appl Physiol. 1988;64(6):2318–23.
41. Allardet-Servent J, Forel JM, Roch A, Guervilly C, Chiche L, Castanier M, et al.
FIO2 and acute respiratory distress syndrome definition during lung
protective ventilation. Crit Care Med. 2009;37(1):202–7. e4-6. doi:10.1097/
CCM.0b013e31819261db.
42. Hoenig JM, Heisey DM. The abuse of power: The pervasive fallacy of power
calculations for data analysis. Am Stat. 2001;55(1):19–24. doi: 10.1198/
000313001300339897.Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
